IL-8 and mTOR counter oxidative stress by inhibiting GSK-3β, while IL-17 stimulates matrix metalloproteinase 7 (MMP7) expression, driving tumor progression through epithelial-mesenchymal transition [93] (Figure 5). The gene discussed is MTOR; the disease is neoplasm.